AVTR
$7.51-0.10 (-1.31%)
Avantor, Inc.
Historical Price
Peer Comparison
Whystock Valuation Model
Fundamentals
Avantor, Inc. engages in the provision of mission-critical products and services to customers in the biopharma, healthcare, education and government, advanced technologies, and applied materials industries in the Americas, Europe, Asia, the Middle Ea...
Recent News
Longleaf Partners Global Fund Increased Its Stake in Avantor (AVTR)
Longleaf Partners, managed by Southeastern Asset Management, released its fourth-quarter 2025 investor letter for “Longleaf Partners Global Fund”. A copy of the letter can be downloaded here. The Fund returned 5.27% in the quarter, compared to the MSCI World’s 3.12 % and the MSCI World Value’s 3.34% return. The Fund returned 16.72% for the year, compared […]
New Strong Sell Stocks for March 17th
AVTR, COIN and CMG have been added to the Zacks Rank #5 (Strong Sell) List on March 17, 2026.
This Life Sciences Supplier Has Plunged 50% in a Year, but One Fund Bought Up $28 Million More in Stock
Avantor delivers laboratory materials and specialized services to biopharma, healthcare, and advanced technology clients worldwide.
Avantor (AVTR): Buy, Sell, or Hold Post Q4 Earnings?
Avantor has gotten torched over the last six months - since September 2025, its stock price has dropped 38% to a new 52-week low of $7.88 per share. This may have investors wondering how to approach the situation.
Why Is Avantor (AVTR) Down 13.6% Since Last Earnings Report?
Avantor (AVTR) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.